Literature DB >> 15855014

HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood.

Ligia A Pinto1, Philip E Castle, Richard B Roden, Clayton D Harro, Douglas R Lowy, John T Schiller, Dora Wallace, Marcus Williams, William Kopp, Ian H Frazer, Jay A Berzofsky, Allan Hildesheim.   

Abstract

Here, we evaluated innate and adaptive immune system cytokine responses induced by HPV-16 L1 VLP in whole blood (WB) cultures from individuals receiving the vaccine (n=20) or placebo (n=4) before and after vaccination. 11 cytokines were measured: IL-1beta, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IFN-gamma, TNF-alpha, and GM-CSF using multiplex bead arrays. Cytokine profiles from WB samples clearly discriminated between vaccine and placebo recipients and between pre and post-vaccination responses. Significant increases in Th1, Th2 and inflammatory cytokines were observed in WB assays following vaccination. Results from WB assays were compared against parallel PBMC-based assays in a subset of patients. Differences between whole blood assay and PBMC were observed, with the highest levels of induction found for WB for several cytokines. Our results indicate that multiplex assays for cytokine profiling in WB are an efficient tool for assessing broad spectrum, innate and adaptive immune responses to vaccines and identifying immunologic correlates of protection in efficacy studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15855014     DOI: 10.1016/j.vaccine.2005.01.146

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  25 in total

1.  Association between tumor necrosis factor alpha rs1800629 polymorphism and risk of cervical cancer.

Authors:  Lanling Wang; Kunpeng Ma; Zhiyong Wang; Yingying Mou; Li Ma; Yong Guo
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 2.  Human papillomavirus disease and vaccines in adolescents.

Authors:  Anna-Barbara Moscicki
Journal:  Adolesc Med State Art Rev       Date:  2010-08

Review 3.  HPV Vaccines: today and in the Future.

Authors:  Anna-Barbara Moscicki
Journal:  J Adolesc Health       Date:  2008-10       Impact factor: 5.012

4.  Comparison of adaptive and innate immune responses induced by licensed vaccines for Human Papillomavirus.

Authors:  Douglas M Herrin; Emily E Coates; Pamela J Costner; Troy J Kemp; Martha C Nason; Kapil K Saharia; Yuanji Pan; Uzma N Sarwar; Lasonji Holman; Galina Yamshchikov; Richard A Koup; Yuk Ying S Pang; Robert A Seder; John T Schiller; Barney S Graham; Ligia A Pinto; Julie E Ledgerwood
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

5.  Immune status of patients with inherited bone marrow failure syndromes.

Authors:  Neelam Giri; Blanche P Alter; Keri Penrose; Roni T Falk; Yuanji Pan; Sharon A Savage; Marcus Williams; Troy J Kemp; Ligia A Pinto
Journal:  Am J Hematol       Date:  2015-05-28       Impact factor: 10.047

6.  Virus-like particles and capsomeres are potent vaccines against cutaneous alpha HPVs.

Authors:  Tilo Senger; Lysann Schädlich; Sonja Textor; Corinna Klein; Kristina M Michael; Christopher B Buck; Lutz Gissmann
Journal:  Vaccine       Date:  2009-12-08       Impact factor: 3.641

7.  Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination.

Authors:  B S Graham; R C Kines; K S Corbett; J Nicewonger; T R Johnson; M Chen; D LaVigne; J N Roberts; N Cuburu; J T Schiller; C B Buck
Journal:  Mucosal Immunol       Date:  2010-06-16       Impact factor: 7.313

8.  Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining.

Authors:  Steven G Smith; Maeve K Lalor; Patricia Gorak-Stolinska; Rose Blitz; Natalie E R Beveridge; Andrew Worth; Helen McShane; Hazel M Dockrell
Journal:  BMC Immunol       Date:  2010-07-07       Impact factor: 3.615

9.  Cytokine and chemokine profiles following vaccination with human papillomavirus type 16 L1 Virus-like particles.

Authors:  Alfonso García-Piñeres; Allan Hildesheim; Lori Dodd; Troy J Kemp; Marcus Williams; Clayton Harro; Douglas R Lowy; John T Schiller; Ligia A Pinto
Journal:  Clin Vaccine Immunol       Date:  2007-06-27

10.  Th2 polarization in peripheral blood mononuclear cells from human immunodeficiency virus (HIV)-infected subjects, as activated by HIV virus-like particles.

Authors:  L Buonaguro; M L Tornesello; R C Gallo; Franco M Marincola; G K Lewis; F M Buonaguro
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.